Why Amedisys Inc (NASDAQ:AMED) Is In News?


Thomson Reuters, a distinguished brokerage company, has placed a 52-week price target of $54.71 on Amedisys Inc (NASDAQ:AMED) shares after it surveyed top market analysts. Calculating estimated earnings after taking into consideration different elements, it is predicted to come at $1.69 for the next fiscal and $N/A for underway quarter.

Valuation Estimates

Analysts take into account the price to earnings ratio to estimate the firm’s valuation. This ratio, which is also called as the P/E ratio evaluates the company on relative expense factor. The formula to calculate ratio is stock’s latest price/ per share earnings. The P/E ratio of Amedisys Inc (NASDAQ:AMED) stands at 42.66.

Analysts also work out Price/Earnings Growth ratio in an attempt to estimate the valuation of a firm. This ratio commonly known as the PEG ratio implies the stock’s valuation compared to earnings growth potential. Investors look to invest in the stocks with a lower PEG ratio. For Amedisys Inc, the PEG ratio for coming 3-5 years is 1.11.

Technical Analysis

The technical analysis highlights that Amedisys Inc current is trading $-2.73 points away or -5.30% from its 50-day moving average of $51.49. Further it is trading $1.97 or +4.21% away its 200-day moving average of $46.79.

The 52-week high of Amedisys Inc (NASDAQ:AMED) was $55.16 while lowest point recorded in 52-week was $31.16. It implies if stock price makes a movement of over $-6.40, it will record a new 52-week high. In the case of +56.48% drop, it will touch a new 52-week low.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 11 times, 1 visits today)